Medical News

RSS

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

The first intestine (bowel) transplant in Michigan was performed on a 50-year-old patient from Port Austin by physicians at Henry Ford Hospital.

23 Sep 2010

CSI to present CALCIUM 360° Study results at TCT symposium

Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.

23 Sep 2010

Nerve inflammation may cause postsurgical neuropathies: Study

A new Mayo Clinic study found that nerve inflammation may cause the pain, numbness and weakness following surgical procedures that is known as postsurgical neuropathy. The development of postsurgical neuropathies is typically attributed to compression or stretching of nerves during surgery. This new research shows that, in some cases, the neuropathy is actually caused by the immune system attacking the nerves and is potentially treatable with immunosuppressive drugs.

23 Sep 2010

Cardiovascular Innovation Institute awarded NIH grant to develop implantable pump for single ventricle heart disease

Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.

23 Sep 2010

DCGI approves ADXS11-001 human testing for cervix cancer

As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.

23 Sep 2010

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.

23 Sep 2010

Federal officials seek stronger workforce safety standards for health workers

Scripps Howard News Service/The (Montgomery County, Pa.) Times Herald: "Federal officials of the Occupational Safety and Health Administration announced this month they will consider proposals from advocacy, labor and student groups that contend work-hour rules proposed by an accreditation council's task force don't go far enough. They're pushing for new caps [on how long medical residents can work] including: No more than 80 hours in any week, compared to current standards that allow for an average of 80 hours.

23 Sep 2010

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.

23 Sep 2010

Scientists develop humanized mouse model to study typhoid fever

Better treatments and prevention for typhoid fever may emerge from a laboratory model that has just been developed for the disease. The model is based on transplanting human immune stem cells from umbilical cord blood into mice that are susceptible to infections.

23 Sep 2010

DSMB authorizes Oxygen Biotherapeutics' next cohort of Oxycyte emulsion study in severe non-penetrating TBI

Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.

23 Sep 2010

Researchers develop drug to eliminate disease transmission by cough

What if there was a drug that could completely eliminate airborne disease transmission that occurs when someone coughs. Researchers at the University of Alberta believe they have found a way to achieve this.

23 Sep 2010

Metabolon publishes biomarker validation study results for periodontal diseases

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Assessment of Dentifrice on Periodontal Disease Biomarkers in Gingival Crevicular Fluid", in the Journal of Periodontology.

23 Sep 2010

Health overhaul offers many flavors of campaign fodder

As the campaign season continues, conflicting narratives emerge about how the health law will factor in to voters' decisions.

23 Sep 2010

Northwestern Medicine participates in world's first human embryonic stem cell clinical trial for spinal cord injury

Northwestern Medicine is the first site open for enrollment in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. Following the procedure, participants will receive rehabilitation treatment at The Rehabilitation Institute of Chicago (RIC).

23 Sep 2010

Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

Evotec AG today announced that it has entered into a collaboration with Almirall S.A. to identify small molecule modulators of an ion channel target, selected by Almirall, involved in respiratory diseases.

23 Sep 2010

Women face sexual function problems after breast cancer

A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70% of women were facing sexual function problems approximately two years post diagnosis.

23 Sep 2010

Generex presents study results of Oral-lyn insulin spray at EASD Annual Meeting

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it is presenting study results at the 46th Annual Meeting of the European Association for the Study of Diabetes being held in Stockholm, Sweden, 20 - 24 September, 2010.

23 Sep 2010

Congress examines health care payment issues and high costs

Congress is preparing to tackle health care issues including reforming the payment system and addressing the high costs of Alzheimer's care, Medicare fraud and long-term disability.

23 Sep 2010

Male partners of women with breast cancer at increased risk of developing mood disorders

A new analysis finds that men whose partners have breast cancer are at increased risk of developing mood disorders that are so severe that they warrant hospitalization. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that clinicians should address the mental health of cancer patients' loved ones.

23 Sep 2010

Study may help develop preventative treatments for womb infections

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have established in mice the mechanism that detects and responds to the presence of bacteria in the womb a discovery that opens up the possibility of new preventative treatments for diseases like pelvic inflammatory disease and Chlamydia.

23 Sep 2010

Medical News

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

CSI to present CALCIUM 360° Study results at TCT symposium

Nerve inflammation may cause postsurgical neuropathies: Study

Cardiovascular Innovation Institute awarded NIH grant to develop implantable pump for single ventricle heart disease

DCGI approves ADXS11-001 human testing for cervix cancer

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

Federal officials seek stronger workforce safety standards for health workers

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Scientists develop humanized mouse model to study typhoid fever

DSMB authorizes Oxygen Biotherapeutics' next cohort of Oxycyte emulsion study in severe non-penetrating TBI

Researchers develop drug to eliminate disease transmission by cough

Metabolon publishes biomarker validation study results for periodontal diseases

Health overhaul offers many flavors of campaign fodder

Northwestern Medicine participates in world's first human embryonic stem cell clinical trial for spinal cord injury

Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

Women face sexual function problems after breast cancer

Generex presents study results of Oral-lyn insulin spray at EASD Annual Meeting

Congress examines health care payment issues and high costs

Male partners of women with breast cancer at increased risk of developing mood disorders

Study may help develop preventative treatments for womb infections

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News